Keyphrases
Pancreatic Cancer
100%
Rac GTPase
100%
Tumorigenesis
100%
Rac1
100%
Mitogen-activated Protein Kinase
81%
Genetically Engineered Mouse Models
27%
Malignant Transformation
18%
Anchorage-independent Growth
18%
PanIN Lesions
18%
Oncogenic Kras
18%
Human Pancreatic Cancer
18%
YAP Protein
18%
Cell-to-cell
18%
Telomerase
9%
KRAS mutation
9%
Expression Activity
9%
Distinct Roles
9%
Tumorigenicity
9%
Phosphoinositide 3-kinase (PI3K)
9%
Cell-matrix Interactions
9%
Effector Pathways
9%
Hippo Pathway
9%
Wnt Signaling Pathway
9%
RAS Oncogene
9%
Signaling Pathway
9%
Transformation Assay
9%
Proposed Work
9%
Metastasis
9%
Transcriptional Repressor
9%
Relative Contribution
9%
Guanine nucleotide
9%
Specific Mechanisms
9%
Specific Intent
9%
PI3K Pathway
9%
Pancreatic Intraepithelial Neoplasia (PanIN)
9%
Yes-associated Protein 1 (YAP1)
9%
Genetic Modification
9%
Dissociation
9%
Pancreatic Duct Cells
9%
Malignancy
9%
Control Genes
9%
Novel Therapeutic Targets
9%
Activating mutation
9%
Transforming Activity
9%
Matrix Interaction
9%
Cancer Development
9%
Oncogenesis
9%
Biochemistry, Genetics and Molecular Biology
GTPase
100%
Mitogen-Activated Protein Kinase
100%
Carcinogenesis
100%
Cooperation
44%
Genetically Engineered Mouse Strain
33%
Mouse Model
33%
Oncogene Ras
22%
Anchorage Independent Growth
22%
Malignant Transformation
22%
Wnt Signaling Pathway
11%
Guanine
11%
Signal Transduction
11%
Drive
11%
Phosphoinositide 3-Kinase
11%
Synapsin I
11%
Botulinum Toxin
11%
Gene Control
11%
Telomerase
11%
Gene Mutation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Guanosine Triphosphatase
50%
Pancreas Cancer
50%
Carcinogenesis
50%
Mouse Model
13%
Genetically Engineered Mouse Strain
13%
Malignant Transformation
9%
Protein Kinase Yes
9%